MNDGX
Price
$15.09
Change
+$0.13 (+0.87%)
Updated
Jul 16 closing price
Net Assets
2.05B
VSGIX
Price
$78.86
Change
+$0.63 (+0.81%)
Updated
Jul 16 closing price
Net Assets
36.92B
Interact to see
Advertisement

MNDGX vs VSGIX

Header iconMNDGX vs VSGIX Comparison
Open Charts MNDGX vs VSGIXBanner chart's image
MFS New Discovery R1
Price$15.09
Change+$0.13 (+0.87%)
VolumeN/A
Net Assets2.05B
Vanguard Small Cap Growth Index I
Price$78.86
Change+$0.63 (+0.81%)
VolumeN/A
Net Assets36.92B
MNDGX vs VSGIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
MNDGX vs. VSGIX commentary
Jul 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MNDGX is a Buy and VSGIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSGIX has more cash in the bank: 36.9B vs. MNDGX (2.05B). VSGIX pays higher dividends than MNDGX: VSGIX (0.55) vs MNDGX (0.00). MNDGX was incepted earlier than VSGIX: MNDGX (20 years) vs VSGIX (25 years). MNDGX (2.04) is less costly to investors than VSGIX (0.06). MNDGX is a more actively managed with annual turnover of: 56.00 vs. VSGIX (21.00). MNDGX has a lower initial minimum investment than VSGIX: MNDGX (0) vs VSGIX (5000000). VSGIX annual gain was more profitable for investors over the last year : 3.92 vs. MNDGX (-1.32). VSGIX return over 5 years is better than : 35.54 vs. MNDGX (-30.74).
MNDGXVSGIXMNDGX / VSGIX
Total Expense Ratio2.030.063,383%
Annual Report Gross Expense Ratio2.040.063,400%
Fund Existence20 years25 years-
Gain YTD2.606-0.701-372%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets2.05B36.9B6%
Annual Yield % from dividends0.000.55-
Returns for 1 year-1.323.92-34%
Returns for 3 years23.2337.7362%
Returns for 5 years-30.7435.54-86%
Returns for 10 years-30.80110.20-28%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARTV2.380.26
+12.26%
Artiva Biotherapeutics Inc
CEP35.241.66
+4.94%
Cantor Equity Partners Inc
CR187.431.68
+0.90%
Crane Company
VCYT25.17-1.48
-5.55%
Veracyte
PHH0.95-0.06
-5.93%
Park Ha Biological Technology Co Ltd